Real-World Evidence and Drug Development

They discuss the importance of collecting real-world evidence from the start of psychedelic research and explore alternative models for drug development and funding. They compare the lack of government support for psychedelic research in the UK to the proactive approach in the US. They express frustration but also optimism for the future of psychedelic research.